Literature DB >> 16944917

Peptidomics for cancer diagnosis: present and future.

Eleftherios P Diamandis1.   

Abstract

Analysis of peptides in biological fluids by mass spectrometry holds promise of providing diagnostic and prognostic information for cancer and other diseases. Before this technology is used clinically, it is important to understand its advantages and limitations. These are summarized, along with proposals, on how to proceed in the future.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944917     DOI: 10.1021/pr060225u

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  23 in total

Review 1.  The blood peptidome: a higher dimension of information content for cancer biomarker discovery.

Authors:  Emanuel F Petricoin; Claudio Belluco; Robyn P Araujo; Lance A Liotta
Journal:  Nat Rev Cancer       Date:  2006-11-09       Impact factor: 60.716

2.  Assessing the social meaning, value and implications of research in genomics.

Authors:  Blanca Lumbreras; Miquel Porta; Ildefonso Hernández-Aguado
Journal:  J Epidemiol Community Health       Date:  2007-09       Impact factor: 3.710

3.  Effects of a Terrified-Sound Stress on Serum Proteomic Profiling in Mice.

Authors:  Juan Yang; Xin Zhang; Xiaofan Xiong; Qiuhua Wu; Lingyu Zhao; Liying Liu; Yannan Qin; Tusheng Song; Chen Huang
Journal:  J Mol Neurosci       Date:  2015-07-09       Impact factor: 3.444

4.  Serum peptidome profiling in patients with gastric cancer.

Authors:  Juan Yang; Yong-Chun Song; Cheng-Xue Dang; Tu-Sheng Song; Zhi-Gang Liu; You-Min Guo; Zong-Fang Li; Chen Huang
Journal:  Clin Exp Med       Date:  2011-07-08       Impact factor: 3.984

5.  Comprehensive analysis of the N and C terminus of endogenous serum peptides reveals a highly conserved cleavage site pattern derived from proteolytic enzymes.

Authors:  Fangjun Wang; Jun Zhu; Lianghai Hu; Hongqiang Qin; Mingliang Ye; Hanfa Zou
Journal:  Protein Cell       Date:  2012-07-16       Impact factor: 14.870

6.  Mechanistic peptidomics: factors that dictate specificity in the formation of endogenous peptides in human milk.

Authors:  Andres Guerrero; David C Dallas; Stephanie Contreras; Sabrina Chee; Evan A Parker; Xin Sun; Lauren Dimapasoc; Daniela Barile; J Bruce German; Carlito B Lebrilla
Journal:  Mol Cell Proteomics       Date:  2014-08-29       Impact factor: 5.911

7.  Profiling of Cross-Functional Peptidases Regulated Circulating Peptides in BRCA1 Mutant Breast Cancer.

Authors:  Jia Fan; Muy-Kheng M Tea; Chuan Yang; Li Ma; Qing H Meng; Tony Y Hu; Christian F Singer; Mauro Ferrari
Journal:  J Proteome Res       Date:  2016-04-26       Impact factor: 4.466

8.  Serum proteomic profiling for autism using magnetic bead-assisted matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a pilot study.

Authors:  Yan-Ni Chen; Hui-Ying Du; Zhuo-Yue Shi; Li He; Yu-Ying He; Duan Wang
Journal:  World J Pediatr       Date:  2018-01-24       Impact factor: 2.764

9.  Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.

Authors:  Dale McLerran; William E Grizzle; Ziding Feng; William L Bigbee; Lionel L Banez; Lisa H Cazares; Daniel W Chan; Jose Diaz; Elzbieta Izbicka; Jacob Kagan; David E Malehorn; Gunjan Malik; Denise Oelschlager; Alan Partin; Timothy Randolph; Nicole Rosenzweig; Shiv Srivastava; Sudhir Srivastava; Ian M Thompson; Mark Thornquist; Dean Troyer; Yutaka Yasui; Zhen Zhang; Liu Zhu; O John Semmes
Journal:  Clin Chem       Date:  2007-11-02       Impact factor: 8.327

10.  Specific Investigation of Sample Handling Effects on Protease Activities and Absolute Serum Concentrations of Various Putative Peptidome Cancer Biomarkers.

Authors:  Irene van den Broek; Rolf W Sparidans; Jan H M Schellens; Jos H Beijnen
Journal:  Clin Proteomics       Date:  2010-09-30       Impact factor: 3.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.